GO:0070070 proton-transporting V-type ATPase complex assembly

The proton-transporting V-type ATPase complex assembly (GO:0070070) is a biological process that governs the formation of a functional V-ATPase, a multi-subunit proton pump that couples ATP hydrolysis to proton transport across membranes. This process is essential for acidification of intracellular organelles such as lysosomes, endosomes, and the Golgi apparatus, and it also operates at the plasma membrane in certain cell types. Because V-ATPase activity influences protein sorting, receptor recycling, and cellular pH homeostasis, defects in its assembly can have profound physiological consequences. Researchers studying this process seek to understand how individual subunits are synthesized, delivered, and assembled into a functional holoenzyme, and how assembly is regulated in response to cellular cues. Recent advances in mass spectrometry-based proteomics have enabled the detection of V-ATPase subunits as potential prognostic markers in diseases such as gastric neuroendocrine neoplasms, underscoring the clinical relevance of this assembly pathway. This article provides a comprehensive overview of the assembly mechanism, key genes, regulatory inputs, disease associations, and experimental strategies for investigating GO:0070070.

GO:0070070, proton-transporting V-type ATPase complex assembly, is defined as the aggregation, arrangement, and bonding together of a proton-transporting V-type ATPase complex, a proton-transporting two-sector ATPase complex that couples ATP hydrolysis to the transport of protons across a concentration gradient. In simpler terms, it is the cellular process that builds a working V-ATPase machine from its individual protein parts.

Understanding GO:0070070 is critical because the V-ATPase complex is a central regulator of cellular pH and organelle function, and its assembly is tightly linked to nutrient sensing, stress responses, and disease pathogenesis. Disruption of V-ATPase assembly can impair lysosomal degradation, autophagy, and receptor signaling, contributing to cancer, neurodegeneration, and metabolic disorders. Moreover, V-ATPase subunits have been identified as potential prognostic markers in type I gastric neuroendocrine neoplasms, highlighting the clinical value of studying this assembly process.

The following genes encode the major subunits and regulators of the proton-transporting V-type ATPase complex, and they are frequently studied in the context of GO:0070070.

V-ATPase assembly is regulated at multiple levels. The mTORC1 signaling pathway promotes the association of V1 and V0 sectors in response to nutrient availability, thereby increasing V-ATPase activity and lysosomal acidification. Conversely, the integrated stress response, mediated by kinases such as EIF2AK3 (PERK), can inhibit V-ATPase assembly under conditions of ER stress. Additionally, the transcription factor TFEB controls the expression of many V-ATPase subunit genes, coordinating assembly with lysosomal biogenesis. Post-translational modifications and interactions with assembly factors further fine-tune the process.

Dysregulated V-ATPase assembly is increasingly recognized as a hallmark of cancer, where it supports the acidic tumor microenvironment, promotes invasion, and contributes to drug resistance. Proteomic studies have identified V-ATPase subunits as potential prognostic markers in type I gastric neuroendocrine neoplasms, suggesting that assembly components could serve as therapeutic targets.

Mutations in V-ATPase subunits, such as ATP6V0A1 and ATP6V1B2, impair assembly and cause neurodegenerative diseases including early-onset epilepsy, hearing loss, and lysosomal storage disorders. Defective assembly leads to impaired lysosomal degradation and accumulation of toxic substrates in neurons.

Altered V-ATPase assembly affects mTORC1 signaling and autophagy, contributing to metabolic syndromes and immune dysfunction. For example, impaired assembly in immune cells can disrupt antigen presentation and cytokine secretion.

Data-independent acquisition mass spectrometry (DIA-MS) combined with liquid chromatography can quantify V-ATPase subunits and identify assembly intermediates in clinical samples, as demonstrated in gastric neuroendocrine neoplasms. This approach enables the discovery of prognostic protein markers related to assembly.

Genome-wide CRISPR knockout or activation screens can identify genes that modulate V-ATPase assembly, using readouts such as lysosomal pH or subunit colocalization. Hits from such screens can reveal novel assembly factors and regulatory pathways.

Fluorescence microscopy with tagged subunits (e.g., GFP-ATP6V0C) allows real-time visualization of assembly and trafficking. Co-immunoprecipitation and blue native PAGE can assess the association of V1 and V0 sectors.

RNA-seq and proteomics can be combined to measure expression changes in V-ATPase subunit genes and proteins under different conditions, providing insights into assembly regulation.

Researchers studying proton-transporting V-type ATPase complex assembly-related genes often need to determine whether a candidate gene is causally involved in assembly, how specific mutations affect function, and what the downstream consequences are. EDITGENE provides a comprehensive suite of CRISPR-based services to address these questions with precision and reproducibility.

GO:0070070, proton-transporting V-type ATPase complex assembly, is a fundamental biological process that builds a multi-subunit proton pump critical for organelle acidification and cellular homeostasis. Its dysregulation is implicated in cancer, neurodegeneration, and metabolic disorders, making it a compelling target for basic and translational research. By leveraging CRISPR-based models and advanced proteomic methods, researchers can uncover the molecular details of assembly and identify new therapeutic opportunities.